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Considerable evidence points to oxidative stress in the brain as an important event in the early stages of Alzheimer’s disease (AD).
The transition metal ions of Cu, Fe, and Zn are all enriched in the amyloid cores of senile plaques in AD. Those of Cu and Fe
are redox active and bind to Aβ in vitro. When bound, they can facilitate the reduction of oxygen to hydrogen peroxide, and of
the latter to the hydroxyl radical. This radical is very aggressive and can cause considerable oxidative damage. Recent research
favours the involvement of small, soluble oligomers as the aggregating species responsible for Aβ neurotoxicity. We propose that
the generation of reactive oxygen species (i.e., hydrogen peroxide and hydroxyl radicals) by these oligomers, in association with
redox-active metal ions, is a key molecular mechanism underlying the pathogenesis of AD and some other neurodegenerative
disorders.
1.Introduction
A large body of evidence supports an important role for
oxidative stress in the pathogenesis of several diﬀerent neu-
rodegenerative diseases, including Alzheimer’s disease (AD),
Parkinson’s disease (PD), the prion disorders, and motor
neuron disease. Under normal physiological conditions,
a balance would be anticipated between pro-oxidant and
antioxidant levels in brain tissue. However, should there
be an imbalance between the two, either as a result of
excessive pro-oxidant levels or deterioration in antioxidant
levels, a build up of reactive oxygen species (ROS) will occur,
resulting in oxidative damage. Evidence of oxidative damage
in AD and other neurodegenerative diseases has been found
in a whole range of studies via a number of established
markers (for recent reviews relevant to AD see, e.g., [1–4]).
Biometal ions, particularly those of Cu, Fe, and Zn,
are also implicated in neurodegenerative disease, including
AD (for some recent reviews see, e.g., [5–7], and references
quoted therein). These ions were found to be enriched in
the amyloid cores of senile plaques in AD sometime ago
(see [8] for a summary) and are important for a number of
reasons. Both Cu and Fe have two readily available oxidation
states (i.e., Cu(II) and Cu(I) and Fe(III) and Fe(II)) which
aid the transfer of electrons and are fundamental to redox
chemistry.Consequentlytheyarereadilyavailableforprotein
binding, can facilitate the Fenton reaction (illustrated in (2)
with respect to Fe ions), and are able to transfer electrons
to oxygen (to form H2O2). They are found as trace-level
contaminants in laboratory buﬀers [8] and are present as
impurities in synthetic Aβ [9]. It has been reported that even
trace concentrations of Zn(II), Cu(II), and Fe(III) are all
suﬃcienttoenhancetheAβ(1–42)initiatedseedingofAβ(1–
40) aggregation [8].
In this paper, we focus our attention on two ROS, that is,
hydrogen peroxide (H2O2) and the hydroxyl radical (•OH).
H2O2 is a cytotoxic oxidant which is freely permeable across
cell membranes and consequently has eﬀectsthat extend well
beyond its site of generation. It is, therefore, likely to be
responsible for global increases in oxidative damage. On the
otherhand,thehydroxylradicalisquitediﬀerent.Itisreadily
formed via Fenton chemistry from H2O2 (see (2)). It is very
reactive, with a reaction rate largely controlled by its rate
of diﬀusion and thus exerts its eﬀects on a very local scale.2 International Journal of Alzheimer’s Disease
Largelybecauseofitshighreactivity,itisalsoveryunselective
in the site of attack and so will react with any biomolecule
thatisimmediatelyadjacenttoitssiteofformation.Themost
commonreactionof •OHishydrogenatomabstractionfrom
the biomolecule, leaving the latter with a radical centre. The
newly formed radical is then available to attack any other
local biomolecule in a reaction typical of a classical chain
reaction. These latter reactions will continue until such a
time as termination occurs.
Until recently, Aβ amyloid ﬁbrils themselves were
believed to be an important toxic agent in AD. Support
for this idea is now under question and presently there
is growing interest in (a) the role of metal ions, and (b)
the involvement of early stage Aβ assemblies (i.e., soluble
oligomers) as the aggregating species potentially responsible
for neurodegeneration in AD. A hypothesis that brings these
two concepts together is the main focus of the remainder of
this brief article.
2. Metal Ions: The DirectGenerationof
ROS and Aβ Oxidation
We now focus on the fascinating possibility that Aβ (and
possibly several other amyloidogenic proteins) might have
the ability to self-generate two important ROS, that is, H2O2
and •OH,duringaggregationinvitro.In1994,Behletal.[10]
reported results suggesting that Aβ could cause increased
levels of H2O2 to accumulate in cells during incubation over
an extended period although the source of the peroxide was
not investigated. However, their results clearly indicate that,
at least in the case of Aβ(25–35), H2O2 levels go through
a maximum before subsequently declining. We believe this
latter ﬁnding to be signiﬁcant and this aspect is discussed
further below.
Two key publications by Huang et al. followed in 1999
[11, 12]. These authors highlighted the direct generation
of H2O2 and •OH during the incubation of solutions of
both Aβ(1–40) and Aβ(1–42). They were able to establish
that Aβ binds to Cu, Fe, and Zn ions and that the bound
peptide can reduce Cu(II) to Cu(I) and Fe(III) to Fe(II). The
binding of these metal ions is most signiﬁcant since they
are elevated in the amyloid deposits found in individuals
with AD [13, 14]. Huang and colleagues were further able
to show that the bound transition metal ions Cu(I) and
Fe(II) were able to reduce molecular oxygen to H2O2 thus
establishing the direct generation of the latter ROS during
peptide incubation. Finally, and of prime importance, is
that their results established that, when bound, both the Fe
and Cu ions are redox active (note that Zn ions are not
redox-active). This redox-active natureofthemetalionwhen
bound to the peptide enables the ready formation of •OH via
the well-known Fenton reaction. This latter observation has
important implications, as discussed in more detail below.
The essential reactions are
O2 +2C u(I)+2 H + −→ H2O2 +2C u(II) (1)
Fe(II)+H 2O2 −→ Fe(III)+
•OH+
−OH (2)
These two reactions have important consequences. The
reduction of oxygen to form H2O2 requires two electrons,
whilst the formation of •OH from H2O2 requires one
electron. It is clear that, in order for (1)a n d( 2) to proceed,
the bound metal ion needs to be in its lower oxidation state
(i.e., either Cu(I) or Fe(II)). If the metal ions are in their
higher oxidation state (i.e., Cu(II) or Fe(III)) the necessary
conversion to their lower oxidation state requires an electron
source. In the absence of any other electron donor it is
possible that, (in vitro), the peptide itself could act as an
electron donor resulting in the formation of the peptide
radical cation:
Aβ/Cu(II) −→

Aβ
•+/Cu(I) (3)
The Aβ radical cation, thus formed, could then undergo
a variety of rapid rearrangement reactions resulting in
the formation of oxidation products consistent with those
commonly observed [1–4]. This process could continue
“longterm”providingtheboundmetalion:peptide complex
remains redox active; that is, there is an interchange between
the two oxidation states of the appropriate metal ion.
However, these reactions could be limited by an inadequate
supply of electrons and it has been questioned if the bound
peptide has the ability to act as an electron donor to Cu(II)
[15].
These results prompted us to carry out our own inves-
tigations, in which only impurity levels of Cu and Fe were
present in samples of Aβ [9, 16]. Puriﬁed synthetic Aβ has
signiﬁcant metal ion content (estimated in our samples as
5.7 × 10
−4 and 1.2 × 10
−3 moles of Fe and Cu, resp., per
mole of Aβ(1–40)) and these levels would be augmented
by additional metal ions present in the buﬀers used [8, 9].
The experimental technique for H2O2 detection was quite
diﬀerent to that employed by Huang et al. and was based
on electron spin resonance (ESR) spectroscopy. Here, H2O2
is converted to •OH via Fenton chemistry and the latter is
detectedbyemployingawell-establishedspin-trappingagent
[9,16].Thuswewereabletoshow,withmanymeasurements
undertaken over an extended incubation period, that Aβ(1–
40), Aβ(1–42), and Aβ(25–35) can all self-generate H2O2
during incubation in solution. On the other hand, related
nontoxicpeptides,suchasthereversepeptideAβ(40–1)were
inactive [9, 16]. Some typical ESR spectra obtained during
theincubationofdiﬀerentAβpeptidesareshowninFigure 1.
At about the same time, a further publication from
Opazo et al. [17] indicated that Huang’s earlier data were
ﬂawed in the sense that a reagent required in their detec-
tion technique, tris(2-carboxyethyl)phosphine hydrochlo-
ride (TCEP), (which was present during incubation) was
found to act, in its capacity as nonbiological reduc-
ing agent, to signiﬁcantly enhance the concentration of
H2O2 generated. Also, when several biological reducing
agents such as vitamin C, dopamine (DA), and L-3,4-
dihydroxyphenylalanine (L-DOPA) were added (separately)
they were found to also considerably enhance H2O2 levels,
although, except in the case of DA, measurements were
taken after only a single time point. These latter observations
are consistent with other research, covering several diﬀerentInternational Journal of Alzheimer’s Disease 3
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Figure 1: ESR spectra of the •OH adduct of 5,5-dimethyl-1-
pyrroline N-oxide (DMPO) recorded after 48h incubation of
(a) Aβ(1–40), (b) Aβ(1–42), (c) Aβ(25–35) (intensity ×1.5) and
(d) Aβ(40–1) at 37◦C and all at 100μM. The intensity of the
spectra observed in (a), (b), and (c) varied with incubation
time as described in the text whereas in (d) no DMPO adduct
spectrum was observed after any period of incubation. Control
samples gave straight line spectra, such as that illustrated in (d),
at every time point examined. The experimental methodology,
reactionconditions,andESRspectrometersettingsarefullydetailed
elsewhere [9, 16].
biological reducing agents [18–20]. The ability of these
biological reducing agents to act as an electron source for
the reduction in the oxidation state of the bound metal ions
reduces the necessity of the peptide itself to do so (3) and,
consequently, enhances the long-term formation of ROS,
especially the •OH radical, so increasing the potential for
oxidative damage.
It is apparent, however, that the presence of biological
(andother)reducingagentsisnottheonlyfactorinﬂuencing
theamountofH2O2 generatedasthemetalion:peptideratio
isalsosigniﬁcant[21].Forexample,H2O2 productionisvery
much enhanced when the Cu(II):peptide ratio in Aβ(1–40)
is increased from 0:1 to 1:1, and it is now apparent that
great care must be taken in assigning enhanced generation of
H2O2when both the reducing agent:Aβ and metal ion:Aβ
ratios are not examined separately. Also measurements
over an extended time period covering many time points
are required as these give information on H2O2 levels as
aggregation progresses.
We mentioned above that particular importance should
be attached to H2O2 generated via the bound peptide.
Not only is there a possibility of a direct reaction between
H2O2 and the bound peptide (and any other accessible
biomolecules) but also the conversion of H2O2 to •OH via
electron transfer from the bound metal ion is signiﬁcant as
this would occur in the immediate vicinity of the peptide.
As outlined above •OH is extremely aggressive and will react
with adjacent molecules, including Aβ itself, with a reaction
rate virtually controlled by diﬀusion. A common reaction
is hydrogen atom abstraction, with the resulting peptidyl
radical undergoing subsequent internal transformation reac-
tions, resulting in oxidation products. If these reactions
do not terminate the radical centre then these peptidyl
radicals could themselves attack other peptide sites (again
via hydrogen atom abstraction) leading to further oxidative
damage until the radical centre is eventually terminated.
As noted above, there is now evidence that, in vivo,R O S
could be involved in the pathogenesis of AD (and other
neurodegenerative diseases) particularly under conditions
where antioxidant defences have deteriorated to the point
where they are unable to cope with the general ROS burden,
possibly as part of the normal ageing process. Under these
conditions not only could H2O2 undergo direct reaction
with any biomolecules encountered but, when arriving at
any appropriate site, such as a redox-active metal bound Aβ,
conversion to •OH in the immediate vicinity of the peptide
would lead to the aggressive reactions described immediately
above.
3. Hypothesis:Soluble Oligomers Are
the Optimal Generatorsof ROS
A key ﬁnding is that oxidative damage has been established
t oo c c u ra sa ne a r l ye v e n ti nA D[ 22, 23] indicating that ROS
activitywouldbeexpectedtobepresentduringanearlystage
of the Aβ aggregation process. Soluble oligomers are likely to
be the major type of Aβ aggregate present during this phase
[24] and so these species become the prime candidate for
involvement in early ROS generation.
Our own results, obtained during the early aggregation
of Aβ(1–40), agree with the above inference [25]. They show
that, in vitro,H 2O2 is generated, during Aβ aggregation, as
a “pulse” during the same time period that atomic force
and electron microscopy images conﬁrm the presence of
small oligomers. Our results reveal a time delay before any
H2O2 is observed, followed by a reasonably rapid increase in
levels which reach a maximum before slowly declining back
towards zero. The latter stage indicates that the rate of H2O2
removal (either through reacting directly with the peptide
or via Fenton chemistry to form •OH) exceeds the rate of
formation.
These observations raise a number of questions. In
particular, what form of Aβ is optimal for the generation
of ROS and why does the ability to generate H2O2 (and the
associated toxicity) appear to decrease as the size of the Aβ
aggregate increases beyond the oligomer stage?
Smallsolubleoligomers(suchasdimersandtrimers)will
have a greater mobility than larger aggregates and so will be
able to diﬀuse from their site of origin and insert into sur-
rounding cell membranes, causing local damage, including
reported changes in membrane permeability [27, 28]. The
ability to generate ROS could also be a particular property
of these small oligomers. A monomer bound to a single
metal ion may not be particularly active in the formation of
H2O2 if this reaction requires the synchronized transfer of
two electrons [29]. Rapid diﬀusion would prevent the close4 International Journal of Alzheimer’s Disease
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Figure2:Solubleoligomers,togetherwiththeirassociatedredox-activemetalions,arepotentiallyresponsibleforthegenerationofH2O2.(a)
Stages of Aβ aggregation, assuming that soluble oligomers are “on pathway” to ﬁbril formation. The optimal conﬁguration for generation
of ROS may be at the small (low-n) oligomer stage. (b) Proposed mechanism for the generation of hydrogen peroxide. Here, Mn and
Mn+1represent Cu(I) and Cu(II), or Fe(II) and Fe(III). The generation of H2O2 requires the synchronized transfer of two electrons from the
bound metal ions and so reaction with the monomer is not favoured. Recent experimental evidence suggests that Cu ions remain bound to
Aβ even inmatureamyloidﬁbrils[26]andsothelackofactivityofhigher-orderaggregates [25]ispossiblyduetosomemetalionsbecoming
sterically removed from any available O2 molecules.
proximity of two such monomers to oxygen, thus impeding
this reaction. Because the generation of H2O2 requires two
electrons, the formation of early-stage oligomers would be
e x p e c t e dt oc r e a t eam o r ef a v o u r a b l es t e r i ca r r a n g e m e n t
for this process to occur. One possible reason why higher-
order aggregates, including mature amyloid ﬁbrils, appear
to lose the ability to generate H2O2 in vitro [25]c o u l db e
that the supply of electrons becomes exhausted, although
it is likely that available reducing agents would be plentiful
in vivo. Another possible reason is that some of the metal
ions associated with Aβ ﬁbrils could lose their redox activity.
The latter could be the result of a steric problem as the
aggregate reaches its solubility limit (and beyond). Here,
some metal ions could become sterically removed (i.e., hid-
den) from the O2 molecule, with H2O2 generation becoming
consequently more diﬃcult. Under these circumstances,
it is quite reasonable to suggest that the most suitable
conﬁguration for generating ROS lies within a range of
optimum oligomer sizes. The latter could also explain the
“time delay” observed in our aggregation experiments before
levels rise, reach a maximum, and then decay [25]. These
arguments lead us to hypothesize that ROS generation is
greatest during the period when small (low-n) oligomers are
the major species present. The many similarities between the
propertiesoftheamyloidogenicproteins/peptidesimplicated
in other neurodegenerative diseases suggests that this type of
mechanism could also apply to other disorders such as PD,
the prion diseases and familial British dementia [9, 16, 25,
30–32].
Finally, it is becoming increasingly recognised that
H2O2 acts as a diﬀusible signaling molecule in the CNS
and is involved in the molecular mechanisms underlying
synaptic plasticity and memory formation [33, 34]. Thus,
the generation of ROS by soluble oligomers of Aβ could
also, potentially, explain their potent eﬀects on long-term
potentiation (LTP), memory, and learning [35, 36].
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